Investments
1Portfolio Exits
1
Want to inform investors similar to Hound Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Hound Partners News
Oct 24, 2022
The Trade Citi names former Goldman Sachs managing director as global head of prime sales New head joins from Hound Partners where he served as COO and before that, spent 25 years at Goldman Sachs. Citi has appointed Tom Lynch, formerly of Goldman Sachs, as its new global head of prime sales. Lynch joins Citi from Hound Partners, where he has spent the past two years serving as chief operating officer. Prior to that, he spent 25 years at Goldman Sachs, leading various teams across prime services sales, capital introduction and capital raising. Based in New York, Lynch will report directly to Fater Belbachir, global head of equities at Citi. Lynch’s appointment follows that of Sebastien Mailleux and Tim Tomalin-Reeves, who were appointed as global co-heads of prime services in June this year. The pair will work alongside Lynch to further grow Citi’s prime services offering. “Tom spent 25 years at Goldman Sachs where he held a number of senior positions within the prime brokerage and capital introductions organisations,” said Belbachir in an internal memo seen by The TRADE. “This experience, combined with his tenure as a COO at Hound Partners, will bring a wealth of client connectivity and leadership to our equities organisation.”
Hound Partners Investments
1 Investments
Hound Partners has made 1 investments. Their latest investment was in Lev Pharmaceuticals as part of their Unattributed VC on October 10, 2006.

Hound Partners Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
10/11/2006 | Unattributed VC | Lev Pharmaceuticals | $21M | Yes |
Date | 10/11/2006 |
---|---|
Round | Unattributed VC |
Company | Lev Pharmaceuticals |
Amount | $21M |
New? | Yes |
Co-Investors | |
Sources |
Hound Partners Portfolio Exits
1 Portfolio Exit
Hound Partners has 1 portfolio exit. Their latest portfolio exit was Lev Pharmaceuticals on October 07, 2008.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
10/7/2008 | Acquired |
Date | 10/7/2008 |
---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources |
Hound Partners Team
1 Team Member
Hound Partners has 1 team member, including current Founder, Jonathan Auerbach.
Name | Work History | Title | Status |
---|---|---|---|
Jonathan Auerbach | Stark Investments, and W.R. Huff Investment Arm | Founder | Current |
Name | Jonathan Auerbach |
---|---|
Work History | Stark Investments, and W.R. Huff Investment Arm |
Title | Founder |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.